Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Chia-Cheng Tsen"'
Autor:
Yung-Che Chen, Ying-Huang Tsai, Chin-Chou Wang, Shih-Feng Liu, Ting-Wen Chen, Wen-Feng Fang, Chiu-Ping Lee, Po-Yuan Hsu, Tung-Ying Chao, Chao-Chien Wu, Yu-Feng Wei, Huang-Chih Chang, Chia-Cheng Tsen, Yu-Ping Chang, Meng-Chih Lin, Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract We hypothesized that epigenetics is a link between smoking/allergen exposures and the development of Asthma and chronic obstructive pulmonary disease (ACO). A total of 75 of 228 COPD patients were identified as ACO, which was independently a
Externí odkaz:
https://doaj.org/article/1877691a9343459ba0123e3ee125f2bc
Autor:
Yung-Che Chen, Meng-Chih Lin, Chih-Hung Lee, Shih-Feng Liu, Chin-Chou Wang, Wen-Feng Fang, Tung-Ying Chao, Chao-Chien Wu, Yu-Feng Wei, Huang-Chih Chang, Chia-Cheng Tsen, Hung-Chen Chen, Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background Controversy exists in previous studies on macrophage M1/M2 polarization in chronic obstructive pulmonary disease (COPD). We hypothesized that formyl peptide receptor (FPR), a marker of efferocytosis and mediator of M1/M2 polarizat
Externí odkaz:
https://doaj.org/article/43729bbcc8e24b0ca9162298fc1e6316
Autor:
Chia-Cheng Tseng, Kai-Yin Hung, Huang-Chih Chang, Kuo-Tung Huang, Chin-Chou Wang, Yu-Mu Chen, Chiung-Yu Lin, Meng-Chih Lin, Wen-Feng Fang
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Purpose This study aimed to investigate the impact of body composition variables on hospital mortality compared to other predictive factors among patients with severe pneumonia. Additionally, we aimed to monitor the dynamic changes in body c
Externí odkaz:
https://doaj.org/article/b7be1e05cc374441b8da417ccf94d026
Autor:
Ying-Huang Tsai, Chin-Chou Wang, Shih-Feng Liu, Yu-Ping Chang, Tung-Ying Chao, Yu-Feng Wei, C Lee, Wen-Feng Fang, Po-Yuan Hsu, Chao-Chien Wu, Huang-Chih Chang, Chia-Cheng Tsen, Yung-Che Chen, Meng-Chih Lin, Ting-Wen Chen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
We hypothesized that epigenetics is a link between smoking/allergen exposures and the development of Asthma and chronic obstructive pulmonary disease (ACO). A total of 75 of 228 COPD patients were identified as ACO, which was independently associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c355b00cbcc4636ae7133d9ab4be79
http://europepmc.org/articles/PMC7930096
http://europepmc.org/articles/PMC7930096
Autor:
Huang‐Chih Chang, Kuo‐Tung Huang, Chia‐Cheng Tseng, Yu‐Mu Chen, Chien‐Hao Lai, Yu‐Ping Chang, Yung‐Che Chen, Hung‐Yi Chuang, Chin‐Chou Wang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 32, Pp 3217-3225 (2023)
Abstract Background The comparative efficacies of different generation tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)‐mutated advanced non‐small cell lung cancer (NSCLC) remain largely unknown. Moreover, whether one
Externí odkaz:
https://doaj.org/article/ab217bd7f0e64d439d644bba985062bb
Autor:
Huang‐Chih Chang, Chin‐Chou Wang, Chia‐Cheng Tseng, Kuo‐Tung Huang, Yu‐Mu Chen, Yu‐Ping Chang, Chien‐Hao Lai, Wen‐Feng Fang, Meng‐Chih Lin, Hung‐Yi Chuang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 32, Pp 3208-3216 (2023)
Abstract Background Despite the well‐established efficacies of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC), there is limited real‐world evidence comparing their effec
Externí odkaz:
https://doaj.org/article/ca8e9bb87fff4e5a8c513be3800911b7
Autor:
Chao-Chien Wu, Chin-Chou Wang, Chia-Cheng Tsen, Yung-Che Chen, Hung-Chen Chen, Meng-Chih Lin, Wen-Feng Fang, Huang-Chih Chang, Shih-Feng Liu, Yu-Feng Wei, Tung-Ying Chao, Chih-Hung Lee
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Journal of Translational Medicine
Journal of Translational Medicine
Background Controversy exists in previous studies on macrophage M1/M2 polarization in chronic obstructive pulmonary disease (COPD). We hypothesized that formyl peptide receptor (FPR), a marker of efferocytosis and mediator of M1/M2 polarization, may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d72183ba690eff1dc33314c93d5c227
https://doi.org/10.1186/s12967-018-1435-5
https://doi.org/10.1186/s12967-018-1435-5
Autor:
Yung-Che Chen, Chien-Hung Chin, Shih-Feng Liu, Chao-Chien Wu, Chia-Cheng Tsen, Yi-Hsi Wang, Tung-Ying Chao, Chien-Hao Lie, Chung-Jen Chen, Chin-Chou Wang, Meng-Chih Lin
Publikováno v:
Disease markers
Disease Markers, Vol 31, Iss 2, Pp 101-110 (2011)
Disease Markers, Vol 31, Iss 2, Pp 101-110 (2011)
Objective:To identify patients at high risk of relapse after anti-tuberculosis (TB) therapy or with poor long-term outcomes.Methods:Fifty-one patients with pulmonary TB: 7 were classified as high association with both cavitations on initial chest rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f03f2b87407092fc34d3e3b149f955b
https://doi.org/10.1155/2011/938794
https://doi.org/10.1155/2011/938794
Autor:
Chin‐Chou Wang, Kuo‐Tung Huang, Huang‐Chih Chang, Chia‐Cheng Tseng, Chien‐Hao Lai, Jui Lan, Ting‐Ting Liu, Chao‐Cheng Huang, Meng‐Chih Lin
Publikováno v:
Thoracic Cancer, Vol 13, Iss 1, Pp 38-47 (2022)
Abstract Background The aim of the study was to assess programmed death‐ligand‐1 (PD‐L1) expression in different histological types and gene mutation status of patients with non‐small cell lung cancer (NSCLC). Methods A total of 4062 patholog
Externí odkaz:
https://doaj.org/article/92accf15ec5642f3ada8baf30c3700ea
Autor:
Chin‐Chou Wang, Chien‐Hao Lai, Yu‐Ping Chang, Huang‐Chih Chang, Chia‐Cheng Tseng, Kuo‐Tung Huang, Meng‐Chih Lin
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3263-3272 (2021)
Abstract Purpose To investigate the survival benefit with first/second generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) and osimertinib in different treatment sequences. Methods We retrospectively screened 3807 pat
Externí odkaz:
https://doaj.org/article/34581f760dc54df492d1a05b4f503c44